The potential for BCP 157 patellar tendonitis treatment is presented by its ability to quick the healing process, diminish inflammation and pain, and enhance functional outcomes
Peptide therapy addresses the root cause : it signals your cells to actually repair the damage, not just mask the pain
Similarly, in dauer larvae, a nonfeeding and developmentally arrested stage of the free-living nematode C
Until the advent of the proprietary form of GGC, Glyteine, there has been no solution for replenishing chronically depleted glutathione
Angiogenesis and VEGF Signalling Research indicates BPC-157 may upregulate vascular endothelial growth factor (VEGF) pathways in experimental models, contributing to: Capillary formation Accelerated wound closure Improved microvascular repair Reference: Hsieh et al., 2017 Angiogenic mechanisms in BPC 157-treated tissues PubMed: 3
The frequency of infusions can vary based on individual needs, ranging from an initial boost of weekly infusions to a maintenance schedule of monthly sessions